TCL Archive Also: NCCN Committee Reaffirms Clinical Guideline Covering Avastin for Breast Cancer Indication July 22, 2011
TCL Archive Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival September 28, 2012